Flow cytometric analysis reagents and consumables

Ended Awarded Last action

Contract number
HHSN26100007
Awardee
Awarding agency
Obligated
$42,997

Award facts

Opportunity
Contract value 100% obligated
$42,996.78 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
San Jose, CA 95131, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00002 -$3,058
Funding Only Action P00001 -$0
Original award $46,055

About this award

The National Cancer Institute issued a delivery order to Becton, Dickinson and Company on July 17, 2015, with a ceiling value of $42,996.78 for flow cytometric analysis reagents and consumables and flow cytometric analysis of benign and malignant tumors.

Place of performance is San Jose, CA 95131. The order was to be completed by March 25, 2020. Pricing is firm fixed price. No set-aside was used for this delivery order.

Quick answers

Who was awarded contract HHSN26100007?

HHSN26100007 was awarded to Becton, Dickinson And Company by National Cancer Institute (National Institutes of Health) on July 17, 2015.

How much is contract HHSN26100007 worth?

The government has obligated $42,997 on HHSN26100007.

Is contract HHSN26100007 an order under another contract?

Yes. HHSN26100007 is a delivery order under HHSN261201400013I, an indefinite delivery contract.

Was contract HHSN26100007 competed?

The extent of competition for HHSN26100007 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award